Sponsor pipeline

Beneficência Portuguesa de São Paulo clinical trial pipeline

Get alerts when Beneficência Portuguesa de São Paulo's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable

    Primary completion pushed from Dec 2026 to Aug 2027

    Also in this update: Primary endpoint(s) modified; Enrollment reduced: 176 → 55 participants

    Beneficência Portuguesa de São PauloPhase 4 NCT06342115 Registry history

    Updated

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 4
1
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06342115 Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized… Febrile Neutropenia Recruiting 2026-09-18
Not applicable
NCT06426277 Effectiveness of the Brazilian Diabetes Prevention Program Prediabetic State Recruiting 2026-06-25
NCT06412549 Effect of a Bundle of Interventions on the Outcomes of Patients With Intracranial Devices… Central Nervous System Infections Not Yet Recruiting 2024-05-14
Not specified
NCT07663357 Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and… Cardiotoxicity Recruiting 2026-06-23

Disease areas by active trials

Diabetes (1) · Heart Disease (1)

Get alerts when Beneficência Portuguesa de São Paulo's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free